Difficulty: Medium
Average Score: 72%
Testbank
A patient with AIDS is admitted to the hospital with AIDS-related wasting syndrome and AIDS-related anorexia. What drug has been found to promote significant weight gain in AIDS patients by increasing body fat stores?
Correct answer
C
Rationale
Megestrol promotes significant weight gain in AIDS patients by increasing appetite and stimulating fat stores, making it an effective treatment for AIDS-related wasting syndrome and anorexia.
Megestrol is a progestin that has been shown to enhance appetite and promote weight gain in patients with AIDS, specifically addressing the challenges of wasting syndrome and anorexia associated with the disease.
A: Advera is an antiretroviral medication primarily used to treat HIV, but it does not specifically address weight gain or the symptoms of wasting syndrome.
B: Momordica charantia, also known as bitter melon, is often used in alternative medicine, but there is insufficient evidence to support its efficacy in promoting weight gain in AIDS patients.
D: Ranitidine is an H2 receptor antagonist used to reduce stomach acid, and it does not have any role in increasing appetite or body fat stores in patients with AIDS.
Megestrol is a progestin that has been shown to enhance appetite and promote weight gain in patients with AIDS, specifically addressing the challenges of wasting syndrome and anorexia associated with the disease.
A: Advera is an antiretroviral medication primarily used to treat HIV, but it does not specifically address weight gain or the symptoms of wasting syndrome.
B: Momordica charantia, also known as bitter melon, is often used in alternative medicine, but there is insufficient evidence to support its efficacy in promoting weight gain in AIDS patients.
D: Ranitidine is an H2 receptor antagonist used to reduce stomach acid, and it does not have any role in increasing appetite or body fat stores in patients with AIDS.